Services

Services organized around a global registration route map, not scattered support points

In medical device and IVD programs, the real difficulty is often the coordination between target markets, evidence requirements, review issues, representative responsibility, and post-market maintenance. LLINS Tech starts by clarifying the route, then connects the dossier and execution rhythm.

Global registration route map

For teams that know the product direction but still need clarity on market sequence, classification, evidence strategy, and resource priorities.

Target-market prioritization, investment order, and timing logic
Classification assumptions and regulatory framework mapping
Dossier reuse potential and critical gap review
Phased route map and next-step recommendations

CE/MDR/IVDR and FDA market access

For EU and US core market programs that need route planning, technical documentation, quality system linkage, and review communication readiness.

MDR / IVDR technical files, clinical or performance evidence, and notified body issue preparation
FDA 510(k), De Novo route review, submission structure, and QMSR linkage
EU representative, US agent, and post-market maintenance coordination

Canada, Australia, Southeast Asia, and Turkey registration

For companies with core-market evidence that want to expand while controlling dossier adaptation cost and representative risk.

Canada and Australia pathway review, including MDSAP / CE / FDA linkage
Southeast Asia dossier adaptation and local requirements coordination
Turkey and other priority markets reviewed project by project

Master dossier and overseas registration function co-build

For companies repeatedly starting multi-market registrations, with dispersed dossier versions and uneven QARA / sales coordination.

Master dossier, evidence matrix, and gap list
Multi-market mapping, version control, and reuse strategy
Role design and rhythm for an overseas registration function

Review diagnosis and Second Opinion

For projects facing NB, FDA, or local authority comments that require external diagnosis of root causes and remediation priorities.

Root-cause breakdown for review comments, NCs, deficiency letters, or return issues
Evidence gaps, cross-document inconsistencies, and submission logic risks
Remediation route, evidence priorities, and communication material suggestions

IVD clinical and innovation-device feasibility

For IVD, POCT, software, AI, or innovation-driven devices that need early judgment on clinical or performance evidence routes.

Clinical, performance, and validation pathway assessment
Innovation registration feasibility, key risks, and evidence gaps
Regulatory milestone planning for R&D, financing, or channel timelines

Representatives and overseas compliance maintenance

For companies entering or already operating in overseas markets that need clearer responsibility boundaries and maintenance rhythm.

EU representative, US agent, and local representative coordination
Certificate maintenance, post-market surveillance, vigilance, and change communication
Representative responsibility boundaries, dossier custody, and internal process suggestions

Typical Engagements

Common starting points

The team wants to go global, but does not know which market comes first

This usually starts with a global registration route map covering market sequence, dossier reuse, and key risks.

CE/FDA materials exist, but expansion is slow

The focus then shifts to master dossier structure, market mapping, evidence matrices, and version control.

Review questions arrived and internal judgment is split

Second Opinion helps diagnose the root cause, evidence route, and cross-document impact before remediation starts.

An innovation or IVD program is still early

Early feasibility work helps avoid discovering clinical or performance evidence gaps too late in development.

Service Boundary

Clear boundaries keep the program controllable

LLINS Tech provides route judgment, dossier organization, issue diagnosis, representative coordination, and maintenance advice. Final decisions remain with regulators, notified bodies, certification bodies, or competent authorities.

Start With The Route

Clarify what to prepare first, instead of starting every workstream at once.

Request route assessment